I always feel an extra shiver of glee when we launch STAT Madness, our annual bracket-style competition in which you, the ...

But the FDA’s decision does not preclude CMS from determining that the higher dose is not reasonable and necessary — ...

The formation of a group called MEHA — Make Europe Healthy Again — may initially seem counterintuitive. Here in the U.S., ...

6 core challenges that researchers must consider as the race to create models that are ever closer to real human embryos ...

The FDA's decision on a chatbot for patients recovering from surgery could offer clues on how the agency plans to regulate ...

The FDA concluded that UniQure's experimental Huntington’s treatment was not providing benefit for patients based on existing clinical data ...

Good morning. It’s March, which means it’s time again for STAT Madness, our annual bracket-style competition in which you vote on the most impactful biomedical research published in the past year.

CMS said Elevance had "substantial and persistent noncompliance" with requirements to submit information about its customers.

The FDA believes that an experimental therapy for Huntington’s disease from UniQure wasn't providing benefit for patients, a senior official told STAT.

A new "Make Europe Healthy Again" movement ties U.S. MAHA figures to European anti-vaccine and far-right networks, raising public health concerns.

Aetna, the health insurance subsidiary of CVS Health, stopped selling Affordable Care Act plans this year. The company said its ACA members had too many medical claims, with CEO David Joyner noting ...

UniQure said Monday that plans to seek approval for its Huntington’s disease treatment with the Food and Drug Administration ...